Predicted Chemotherapy Benefit for Breast Cancer Patients With Germline Pathogenic Variants in Cancer Susceptibility Genes is a research paper published in JNCI Cancer Spectrum (2020). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCCDPHP CDC HHS
Grant: NU58DP006344
NCI
Grant: 5NU58DP006352-03–00
University of Southern California
Grant: HHSN261201800009I
NCI NIH HHS
Grant: HHSN261201800015I
National Institutes of Health
Grant: R01 CA225697
National Institutes of Health
Grant: HHSN26100001
NCI NIH HHS
Grant: HHSN261201800003C
NCI NIH HHS
Grant: HHSN261201800032C
California Department of Public Health pursuant to California Health
Grant: 5NU58DP006344
NCI NIH HHS
Grant: HHSN261201800009C
NCI NIH HHS
Grant: HHSN261201800015C
California Department of Public Health pursuant to California Health
Grant: HHSN261201800032I
National Institutes of Health
Grant: HHSN261201800003I
National Institutes of Health
Grant: 5R01CA225697-03
Genetic testing, treatment use, and mortality after diagnosis of breast and ovarian cancer: The Georgia-California GeneLINK Initiative
National Cancer Institute
FWCI
0.48
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals